Septerna

We were thrilled to welcome our distinguished scientific founders to Septerna HQ last week: ??Robert Lefkowitz, MD, (Septerna Scientific Founder), Duke University, Chancellor’s Distinguished Professor of Medicine and Professor of Biochemistry and Chemistry. ??Arthur Christopoulos, PhD, (Septerna Scientific Founder), Monash University, Dean of Faculty of Pharmacy & Pharmaceutical Sciences. ??Patrick Sexton, PhD, DSc, (Septerna Scientific Founder), Monash University, Professor (Research), Drug Discovery Biology. ??Denise Wootten, (Septerna Scientific Advisor), Monash University, Professor (Research), Drug Discovery Biology. Their ongoing collaboration through lectures and roundtable discussions with our team is invaluable as we advance our pipeline of differentiated GPCR-targeted candidates. #DrugDiscovery #GPCRs #Biotech #Innovation

This Black History Month, #TeamSepterna celebrated the profound impact and invaluable contributions of African Americans throughout history.?? ? Our team came together last week to learn, reflect, and celebrate Black history. We engaged in educational activities and team building to create continued appreciation of Black culture.? ? At Septerna, we know that diverse perspectives and experiences strengthen our ability to innovate and advance therapies for patients in need.?? ? #BlackHistoryMonth #BHM2025 #AfricanAmericanHistory

Join us at the 45th Annual TD Cowen Healthcare Conference on March 5th at 10:30 AM ET in Boston. Our CEO and Co-founder, Jeff Finer, M.D., Ph.D., will discuss the progress we are making towards unlocking the therapeutic potential of GPCRs through our innovative pipeline targeting endocrinology, immunology, and metabolic diseases. https://bit.ly/3QBpLGH #BiotechInnovation #GPCRs #TDCowenHealthcare

This International Day of Women & Girls in Science, we’re proud to spotlight Jun Zhang, Senior Director, Disease Biology at Septerna. Her journey from studying butterfly patterns to discovering breakthrough therapeutics exemplifies the power of scientific curiosity and perseverance. ? Jun has played a key role in developing SEP-786, our clinical-stage therapeutic candidate for chronic hypoparathyroidism. Her work demonstrates how women in STEM are driving innovations that have the potential to transform patient care. ? Join us in celebrating Jun and all women advancing scientific discovery. Their diverse perspectives and dedication are essential to solving today’s most challenging medical needs. #WomenInScience #WomenInSTEM #Innovation #IDWGS2025

Join Septerna CEO Jeff Finer at #BIOCEO25 on February 10 as he shares insights from our successful IPO journey alongside fellow biotech leaders. Catch him at 3 PM ET on the “Voices from the IPO Class of 2024” panel, moderated by Eric Joseph, PhD of J.P. Morgan. https://bcic.bio.org/ We Look forward to connecting with the biotech community in NYC! Biotechnology Innovation Organization #biotechIPO

Innovation thrives when different perspectives come together. From our Native Complex Platform? to our inclusive workplace culture, Septerna is built on this principle. Celebrating Lunar New Year as a team reminds us that our strength lies in our diversity as we work toward our shared mission of developing breakthrough GPCR-targeted therapies for patients. #LunarNewYear2025 #DiversityInBiotech #InnovationThroughInclusion #LifeAtSepterna

We recently celebrated Septerna’s 3rd anniversary of pioneering innovative therapeutics through groundbreaking science and collaboration. As we reflect on our journey, we remain committed to our mission of developing life-changing medicines for all the patients who are counting on us. Happy 3rd Anniversary to the incredible #TeamSepterna! #Team #Collaboration #BiotechInnovation #PatientFocus

ICYMI: Our CEO Jeff Finer joined industry leaders at Fierce Life Sciences Events #FierceJPMWeek to discuss the evolving biotech landscape, IPOs, and market outlook for 2025. Jeff shared his key insights during the panel discussion: ?? Clinical data will be the driving force for biotech success in 2025 ?? Strategic timing and preparation are crucial for successful IPOs ?? Breakthrough innovations that benefit patients will lift the entire biotech sector Missed the live discussion? Watch the recording by registering for the free virtual event: https://loom.ly/Rkd0jNo #Biotech #JPM2025 #BiotechMarkets #IPO

Join us in person or via webcast this afternoon for Septerna’s #JPM25 podium presentation. We look forward to reviewing the progress we’ve made towards our mission to unlock the therapeutic potential of GPCRs while advancing patient-focused treatments across multiple therapeutic areas. https://bit.ly/3DTBc9C?? ? #BiotechInnovation #GPCRScience??

We're thrilled to announce Gil Labrucherie has joined Septerna as Chief Financial Officer! As a seasoned biopharma executive with more than 25 years of senior leadership experience in finance and legal roles for public biopharmaceutical and technology companies, Gil will be instrumental as we advance SEP-786 and our pipeline of oral small molecule GPCR programs. https://lnkd.in/g5rzP-j4 #BiotechLeadership #GPCR